The global glycobiology market is poised for significant growth in the coming years. Valued at approximately USD 0.65 billion in 2024, the market is expected to grow to USD 0.75 billion by 2025 and reach approximately USD 2.63 billion by 2034. This represents an impressive Compound Annual Growth Rate (CAGR) of 14.91% between 2025 and 2034. In this article, we explore the trends, top players, and key insights driving the growth of the glycobiology market.
Key Takeaways:
-
Market Size in 2024: The glycobiology market is expected to cross USD 0.65 billion in 2024.
-
Growth Forecast: Projected to reach USD 2.63 billion by 2034.
-
CAGR: Estimated to grow at a rate of 14.91% from 2025 to 2034.
-
Leading Region: North America accounted for around 40% of the market share in 2024.
-
Asia Pacific: This region is anticipated to grow at the fastest CAGR of 12-14% over the forecast period.
-
Dominant Product Segment: The reagents and kits segment was the leader in 2024, holding nearly 35% of the market share.
-
Rapid Expansion: The glycoengineering and synthesis services segment is projected to grow at 15% CAGR between 2025 and 2034.
-
Technology Segment: The mass spectrometry-based glycomics segment held a dominant 40% share in 2024.
Leading Companies in the Glycobiology Market
Several companies play a crucial role in shaping the growth of the glycobiology market. These industry leaders offer advanced products and services that are revolutionizing research and applications in glycobiology. Below are the key players in the market:
1. Thermo Fisher Scientific
About: Thermo Fisher Scientific is a global leader in scientific services, specializing in instruments, reagents, and consumables.
Products: Their glycobiology offerings include glycan analysis, carbohydrate analysis, and glycobiology-related reagents.
Market Cap: Thermo Fisher’s market capitalization is approximately USD 240 billion.
2. Agilent Technologies
About: Agilent Technologies is renowned for its life sciences and diagnostics solutions, providing innovative tools for researchers in glycobiology.
Products: Agilent offers a wide range of instruments and reagents for mass spectrometry, chromatography, and molecular biology.
Market Cap: Agilent Technologies holds a market cap of USD 45 billion.
3. Waters Corporation
About: Waters Corporation is a leading provider of analytical instruments, reagents, and services used in glycomics and glycobiology research.
Products: Known for its chromatography and mass spectrometry systems, Waters helps advance glycobiology studies.
Market Cap: Waters Corporation’s market cap stands at USD 20 billion.
4. Merck KGaA (Sigma-Aldrich)
About: Merck KGaA is a global scientific and technology company, with Sigma-Aldrich being its life sciences arm.
Products: The company provides a wide range of glycobiology reagents and assays for researchers and industry professionals.
Market Cap: Merck KGaA has a market cap of approximately USD 40 billion.
5. New England Biolabs
About: Specializing in biochemistry, New England Biolabs supplies reagents and tools for glycobiology research, particularly in gene editing and molecular biology.
Products: The company provides enzymes and other reagents used in glycomics and biotechnology applications.
Market Cap: New England Biolabs is privately held, with its financial details undisclosed.
6. Promega Corporation
About: Promega offers a diverse array of reagents and technologies for life sciences research, including glycobiology.
Products: Their glycobiology products include tools for glycan analysis, glycoprotein analysis, and more.
Market Cap: Promega is a privately held company.
7. Vector Laboratories
About: Vector Laboratories offers specialized reagents, including lectins and enzymes, that support glycobiology research.
Products: Their product range includes glycoprotein detection, lectins, and other glycobiology-related tools.
Market Cap: Vector Laboratories is privately held.
8. Ludger Ltd.
About: Ludger Ltd. specializes in glycobiology-related services, including glycan analysis and glycoprotein profiling.
Products: Their products focus on glycomics and proteomics, providing services and tools for carbohydrate analysis.
Market Cap: Ludger Ltd. is privately held.
9. ProZyme (Shimadzu & Agilent JV)
About: ProZyme, a joint venture between Shimadzu and Agilent, provides tools for glycan analysis and glycoprotein research.
Products: Their glycomics products include glycan release kits and glycoprotein purification reagents.
Market Cap: Market cap is undisclosed as ProZyme is a privately held company.
10. Elicityl SA
About: Elicityl SA focuses on the development of custom glycosylation services for glycobiology applications.
Products: Elicityl’s products include glycosylated peptides, glycoproteins, and other glycobiology services.
Market Cap: Elicityl SA is privately held.
11. Oxford GlycoSciences (OGS)
About: OGS offers cutting-edge solutions for glycobiology research, including tools for glycan analysis and profiling.
Products: Their offerings include glycan arrays and other molecular biology products.
Market Cap: Oxford GlycoSciences is privately held.
12. Qiagen
About: Qiagen is a global leader in providing sample preparation and testing solutions, including for glycobiology applications.
Products: Qiagen offers reagents and kits for glycan and glycoprotein research.
Market Cap: Qiagen has a market cap of approximately USD 10 billion.
13. Bruker
About: Bruker develops high-quality analytical instruments used in glycobiology research, especially mass spectrometry-based technologies.
Products: Bruker provides solutions for glycan analysis and proteomics research.
Market Cap: Bruker has a market cap of approximately USD 15 billion.
14. JEOL Ltd.
About: JEOL Ltd. is known for its electron microscopes and mass spectrometers, which are pivotal in glycobiology research.
Products: Their products support research in glycomics and molecular biology.
Market Cap: JEOL Ltd. has a market cap of approximately USD 3 billion.
15. Genovis AB
About: Genovis specializes in glycoprotein and glycan analysis services for researchers in the life sciences.
Products: Genovis offers enzymes and reagents for glycan and glycoprotein analysis.
Market Cap: Genovis AB has a market cap of approximately USD 1 billion.
16. Takara Bio
About: Takara Bio is a leading biotechnology company that provides a variety of reagents and services for glycobiology research.
Products: Takara Bio offers enzyme products and kits for glycosylation analysis.
Market Cap: Takara Bio has a market cap of approximately USD 3 billion.
17. Sartorius AG
About: Sartorius is a global supplier of laboratory and process technology, supporting glycobiology research with innovative solutions.
Products: Sartorius offers high-quality instrumentation and reagents for glycobiology.
Market Cap: Sartorius AG has a market cap of approximately USD 50 billion.
18. Analytik Jena
About: Analytik Jena specializes in analytical instruments and laboratory tools for various life sciences applications, including glycobiology.
Products: Their products support glycan analysis and glycoprotein research.
Market Cap: Analytik Jena is publicly traded, with a market cap of approximately USD 2 billion.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
FAQs About the Glycobiology Market
1. What is the glycobiology market’s expected growth rate?
The glycobiology market is expected to grow at a CAGR of 14.91% between 2025 and 2034, reaching USD 2.63 billion by 2034.
2. Which region leads the glycobiology market?
North America led the market with around 40% of the revenue share in 2024.
3. What are the dominant product segments in the glycobiology market?
The reagents and kits segment held the largest share of the market, capturing nearly 35% in 2024.
4. Which technology is expected to dominate the glycobiology market?
Mass spectrometry-based glycomics held a dominant 40% revenue share in 2024 and is expected to continue driving growth.
5. What are the fastest-growing segments in the glycobiology market?
The glycoengineering and synthesis services segment is projected to register 15% CAGR from 2025 to 2034.
This report offers an insightful look into the growth prospects and leading companies in the glycobiology market, highlighting key players and market trends that are shaping the future of this industry.
Source : https://www.towardshealthcare.com/insights/glycobiology-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5909
About the Author
